Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms
Lorenz Thurner, Natalie Fadle, Bernhard Thurner, Igor Age Kos, Moritz Bewarder, Evi Regitz, Birgit Bette, Yvan Fischer, Vadim Lesan, Torben Rixecker, Marie-Christin Hoffmann, Klaus-Dieter Preuss, Claudia Schormann, Dominic Kaddu-Mulindwa, Klaus Roemer, Onur Cetin, Sebastian Mang, André Becker, Frede · 2026
Read Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms by Lorenz Thurner, Natalie Fadle, Bernhard Thurner, Igor Age Kos, Moritz Bewarder, Evi Regitz, Birgit Bette, Yvan Fischer, Vadim Lesan, Torben Rixecker, Marie-Christin Hoffmann, Klaus-Dieter Preuss, Claudia Schormann, Dominic Kaddu-Mulindwa, Klaus Roemer, Onur Cetin, Sebastian Mang, André Becker, Frede (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13219524.txt.
Description
Lorenz Thurner and colleagues link severe COVID-19 to autoantibodies against two of the body's inflammation brakes in a 2026 study. Some patients' immune systems attack their own proteins, and this work concerns interleukin-1 receptor antagonist and progranulin, blockers of two strong inflammatory signals. When antibodies block those blockers, inflammation can run free.
The autoantibodies appeared with chemically altered, hyperphosphorylated versions of the two proteins, formed complexes with them, lowered their levels in blood, and left the inflammatory signals they usually restrain more active. Using custom antibody fragments, the team tracked the altered proteins and the autoantibodies across a German pandemic cohort. Most positive patients carried both autoantibodies; levels peaked early and faded over twelve months, and the altered proteins disappeared first. Seropositivity tracked with hyperinflammation. Inflammatory signals themselves could force the alteration in blood cells, but at doses up to a thousand times higher than in cells from positive survivors.
Catalog record
| CREATOR | Lorenz Thurner, Natalie Fadle, Bernhard Thurner, Igor Age Kos, Moritz Bewarder, Evi Regitz, Birgit Bette, Yvan Fischer, Vadim Lesan, Torben Rixecker, Marie-Christin Hoffmann, Klaus-Dieter Preuss, Claudia Schormann, Dominic Kaddu-Mulindwa, Klaus Roemer, Onur Cetin, Sebastian Mang, André Becker, Frede |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 89 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |